- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 573
Finix finishes series B fundraise with $35m
The Visa-backed enterprise payment software producer will use the series B funds for hiring, product development and international growth.
Feb 5, 2020Automox locks up $30m
The cybersecurity software developer has now raised $42m altogether, Koch Disruptive Technologies leading a series B round that included CrowdStrike's Falcon Fund.
Feb 5, 2020ALD NanoSolutions forges ahead with $20m
CU Boulder spinout ALD NanoSolutions has merged with its peer Forge Nano, with new merged company securing $20m from a range of corporates.
Feb 5, 2020Labelbox indicates $25m series B round
Google unit Gradient Ventures came back for a round that increased the AI data training startup's overall funding to nearly $39m in under two years.
Feb 5, 2020Lightship sails to $20m series B
McKesson Ventures co-led the first round to be disclosed by the clinical trial services provider, which will put the money into recruitment and improving its technology platform.
Feb 5, 2020ECMC fires up new accelerator
OnRamp Education & Workforce Innovation Accelerator has been launched by ECMC Group and Gener8tor and will provide each participant with $100,000 in funding.
Feb 4, 2020Astra rockets out of stealth mode
Airbus Ventures is among the investors in the spacecraft developer, which has raised in excess of $100m in funding altogether.
Feb 4, 2020Passage Bio reaches IPO stage
University of Pennsylvania-linked CNS disorder-focused drug developer Passage Bio has filed to raise up to $125m having raised $226m in funding.
Feb 4, 2020Revolution to make waves with IPO
The cancer therapy developer is set to raise between $140m and $160m in its initial public offering, following $226m in funding.
Feb 4, 2020Aspect impresses to collect $19.6m
The UBC bioprinting spinout will use part of the funding to progress two of its projects towards commercialisation.
Feb 4, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


